The <scp>SQ</scp> tree sublingual immunotherapy tablet is effective and well tolerated in children—A pivotal phase <scp>III</scp> trial
This is the first paediatric trial to provide robust evidence of efficacy and safety of the SQ tree SLIT-tablet in tree pollen-induced AR/C in a paediatric population (5-17 years).
Authors
- Ewa Cichocka‐Jarosz (ORCID: https://orcid.org/0000-0002-8428-5976)
- Oliver Pfaar (ORCID: https://orcid.org/0000-0003-4374-9639)
- Ján Mikler
- Terrie Dalgaard
- Andrzej Emeryk (ORCID: https://orcid.org/0000-0003-1853-8696)
- F. Horák
- Kenneth Hargreaves (ORCID: https://orcid.org/0000-0002-1076-4931)
- Monika Gappa (ORCID: https://orcid.org/0009-0006-8001-1165)
- Rémi Gagnon
- Kirsten Hansen
Institutions
- Medical University of Lublin (PL)
- Jagiellonian University (PL)
- Philipps University of Marburg (DE)
- Gentofte Hospital (DK)
- Evangelisches Krankenhaus Düsseldorf (DE)
- ALK-Abelló (Denmark) (DK)
- Allergiezentrum Wien West (AT)
- Comenius University Bratislava (SK)
Publication Details
- Journal
- Allergy
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1111/all.16363
- Citations
- 12
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 4.59